Plasma chemerin is increased in chronic inflammatory diseases, and elevated circulating chemerin levels is positively associated with detrimental effects in lipid, glucose and cytokine homeostasis, serving as a connection among obesity, metabolic disorders, and inflammation [7,8,9,10,11]. The gene discussed is RARRES2; the disease is obesity due to melanocortin 4 receptor deficiency.